HENRY CHRISTIAN O 4

What Happened Henry Christian O, a non-employee director of Ginkgo Bioworks Holdings, Inc. (DNA), was granted 25,000 restricted stock units (RSUs) on June 11, 2026. The grant is reported as a derivative award (no purchase price reported). Each RSU represents a contingent right to one share of Class A common stock; the filing lists the award value/price as N/A.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15.
• Security: 25,000 RSUs (derivative); price per share: N/A.
• Shares owned after the transaction: Not reported in this filing.
• Vesting: RSUs vest on the earlier of June 11, 2027 or the day immediately prior to the next annual meeting, conditioned on continued service as a non-employee director (per filing footnote).
• Filing timeliness: The Form 4 was filed four days after the transaction date; Form 4s are generally due within two business days, so this appears later than standard reporting expectations.

Context RSUs are a grant (compensation) rather than an open-market purchase or sale. They convert into actual shares only if and when they vest (subject to continued board service) and may be subject to tax withholding at settlement. Such awards are a routine part of director compensation and do not, by themselves, indicate buying or selling sentiment.